For the Quarter Ending September 2022
North America
In North America, the prices of Calcium Powder (USP Grade) declined by around 11.8% for Calcium Carbonate and 9.9% for Calcium Citrate due to unfavorable sentiments in the regional market during the third quarter of 2022. In terms of demand, there was weakened demand and offtakes from downstream pharmaceutical and nutraceutical industries. In terms of supply, there were ample inventories in the market, and suppliers met the overall order of regional and overseas buyers, which affected the Calcium Powder market. Therefore, by the end of the quarter, the prices for Calcium Carbonate and Calcium Citrate settled at USD 810/MT and USD 4150/MT in September 2022, respectively.
Asia- Pacific
During the third quarter of 2022, the Calcium Powder market exhibited sluggish market sentiments across the Asia Pacific region, with prices settling at USD 548/MT for Calcium Carbonate and USD 3220/MT for Calcium Citrate in September. The manufacturers of Calcium Powder in the Chinese market had high inventory, so the market stock was abundant. Also, the production cost for the pharmaceutical grade continued to deteriorate throughout the quarter, prompting producers to keep the prices lower. Both the poor offtakes and bleak demand for Calcium Powder from downstream pharmaceutical industries resulted in a downward trend.
Europe
The price movement of Calcium Powder scaled down in the European market during the third quarter of 2022. The decline was due to sufficient inventory in the german domestic market. Also, the European demand decreased significantly post-inflation because product offtakes remained less from the regional market by the end-user pharmaceutical producers, who were cautious before making any purchase. The companies reduced their profit margins to increase the trade of goods in the market, which further levied its impact on the offers for the pharma and industrial grade in the European market. Also, depreciated currency values further reflected the prices negatively.
For the Quarter Ending June 2022
North America
In the North American region, the Calcium Powder market demonstrated a static price trajectory during the second quarter of 2022. Domestic traders and buyers were concerned about high raw material prices throughout the quarter due to high inflation, the problematic political situation between Russia and Ukraine, and the very unpredictable nature of oil prices. Long-lasting port and supply constraints persisted during the whole quarter in the US market. Offtakes from the downstream industries, such as pharmaceutical and nutraceutical, were constant in demand.
Asia
The Asia Pacific Calcium Powder market displayed stagnant sentiments in the second quarter of 2022. After the ports and factories began operations in the first part of the quarter, calcium powder production in China surged. After a subsequent rise in COVID-19 cases in the final week of April, the Chinese government once more put important production facilities on lockdown, which impacted the country's nutraceutical markets. On the demand front, offtakes from the end-user industries remained steady during the quarter. The country's Zero-COVID policy caused several cargo ships to become stuck at ports, thus hindering the shipment of the goods to other markets. Later, in the second half of the quarter, a number of plants went under maintenance, contributing to the market decline for calcium powder in China. In order to get rid of stockpiles before they degraded due to the high COVID customs, numerous factories were prepared to offer the goods at a discount toward the end of the quarter.
Europe
Calcium Powder prices in Europe followed the same pattern as in North America in Q1 2022, as demand from downstream sectors remained robust throughout the quarter. Calcium Powder has become a must for consumers, particularly in developed markets such as the European region, particularly in the pharmaceutical and nutraceutical industries, resulting in increased demand in the region. Throughout the quarter, the market was exacerbated by rising raw material and freight costs and long-term supply chain problems.
For the Quarter Ending March 2022
North America
Calcium Powder's domestic market remained stagnant in the first quarter of 2022, but demand and sentiments increased, drawing attention. During the first half of Q1 2022, the US markets remained demand-driven, and supply-chain limited, with signs of improving labor resources and supplier delivery performance. A large increase in demand for Calcium Powder from end-user businesses, on the other hand, resulted in a price increase across the country. In the month of March, calcium carbonate prices for USP and food grade were fixed at USD9340/mt and USD865/mt, respectively. Increased raw material, energy, transportation, services, and logistics costs in China aided this pricing adjustment in the country.
Asia Pacific
The price trend of Calcium Powder increased little in the Asia Pacific region during Q1 2022, when market attitudes improved following the Lunar New Year slump. Due to sustained demand from downstream sectors and a growth in Omicron variant cases in the country, calcium powder consumption in the domestic market remained strong. The market trend in China has been bolstered by rising raw material and energy costs. The introduction of the zero-tolerance covid policy, on the other hand, has had a severe impact on the supply chain of various commodities across the country, including Calcium Carbonate and Calcium Citrate. Calcium Citrate for USP and Food grade was valued at USD2280/mt and USD4300/mt, respectively, in the negotiations. On the same day, pricing for USP and Food grade calcium carbonate were fixed at USD9835/mt and USD680/mt, respectively. The markets rose sharply after operations resumed on February 27 and stayed stable through the end of March.
Europe
Calcium Powder prices in Europe followed the same pattern as in North America in Q1 2022, as demand from downstream sectors remained robust throughout the quarter. Calcium Powder has essentially become a must for consumers, particularly in developed markets such as the European region, particularly in the pharmaceutical and nutraceutical industries, resulting in increased demand in the region. Throughout the quarter, the market was exacerbated by rising raw material and freight costs, as well as long-term supply chain problems.
In the Asian market, the pricing trend of Calcium Powder demonstrated an upward trajectory during the fourth quarter of 2021 followed by the stable demand from the downstream sectors. In the Chinese domestic market, the cost support from the upstream Citric Acid consistently weakened during the first week of Q4 which resulted in the plunged offers of Calcium Citrate across China. The FOB Shanghai discussions for Calcium Citrate were assessed at USD 4340/ MT and USD 2150/MT for the USP and Food grades respectively in the fourth week of November. Whereas discussions for the Calcium Carbonate settled at USD 9604 per tonne and USD 440 per tonne for the USP and Food grades respectively, during the week ending 26th November, taking cues from the high feedstock values. Due to the increase in the production costs, several Calcium manufacturing companies further increased the market prices and passed on the pressure on to the buyers including Yiyang Zhenbang which rose the prices for all its calcium products in October starting. Meanwhile, in India, slow improvements were observed for Calcium Citrate during the first half of this quarter. In terms of demand, strong offtakes from the downstream industries were observed throughout Q4 on the back of the skyrocketed freight charges along various Asian trade routes.
The market sentiments improved in the European market during the 4th quarter of 2021 on the back of the increased demand from downstream pharma grade industry. However, the supply outlook of several Nutraceutical products including Calcium Powder remained disrupted due to the energy crises across Europe. The skyrocketed raw material prices and high freight charges has further supported the market trend throughout the fourth quarter.
